ENZO BIOCHEM, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
ENZO BIOCHEM, INC. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $19.95 million for the 9-month period ending 2023-04-30, per its 10-Q filed 2023-06-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2023-06-14
- ENZO BIOCHEM, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2023-04-30 was $5.05M.
- ENZO BIOCHEM, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2023-01-31 was $6.20M.
- ENZO BIOCHEM, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2022-10-31 was $8.69M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month |
|---|---|---|---|
| 2023-04-30 | $5.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-14 | $11.25M derived: sum of 2 quarters · filed 2023-06-14 | $19.95M 10-Q · filed 2023-06-14 |
| 2023-01-31 | $6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-20 | $14.89M 10-Q · filed 2023-03-20 | |
| 2022-10-31 | $8.69M 10-Q · filed 2022-12-12 |